Breast Neoplasms, Male: all 123 studies

Page 1 of 2. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2Not yet recruitingNCT07558343Not applicable
• Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyRecruitingNCT06805812
• MALE Mamm OrganoidsRecruitingNCT06786663
• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceRecruitingNCT06492616Phase 3
• Access to Genetic Testing in Underserved Patients With CancerRecruitingNCT06422455Not applicable
• The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world StudyRecruitingNCT06220630
• ETHAN - ET for Male BCRecruitingNCT05501704Phase 2
• A Study of PF-06873600 in People With CancerTerminatedNCT03519178Phase 1/2Results posted
• Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast CancerCompletedNCT03112590Phase 1/2Results posted
• Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast CancerCompletedNCT03018080Phase 2Results posted
• Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)CompletedNCT02950259Phase 1Results posted
• Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerTerminatedNCT01938833Phase 1/2Results posted
• FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast CancerTerminatedNCT01931709Not applicableResults posted
• FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast CancerCompletedNCT01928186Not applicableResults posted
• Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast CancerCompletedNCT01869764Phase 2Results posted
• Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast CancerTerminatedNCT01868503Phase 2Results posted
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
• Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone TherapyCompletedNCT01720602Not applicableResults posted
• S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerActive, not recruitingNCT01674140Phase 3Results posted
• Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast CancerTerminatedNCT01394211Phase 2Results posted
• Azacitidine and Entinostat in Treating Patients With Advanced Breast CancerCompletedNCT01349959Phase 2Results posted
• RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerTerminatedNCT01217411Phase 1/2Results posted
• Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor TherapyCompletedNCT01153672Not applicableResults posted
• Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast CancerTerminatedNCT01151449Phase 2Results posted
• Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast CancerCompletedNCT01042535Phase 1/2Results posted
• Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With CancerCompletedNCT01037790Phase 2Results posted
• Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by SurgeryCompletedNCT00861705Phase 2Results posted
• Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast CancerCompletedNCT00821964Phase 2Results posted
• Vaccine Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT00791037Phase 1/2Results posted
• Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryCompletedNCT00770809Phase 3Results posted
• Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00699491Phase 1/2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast CancerActive, not recruitingNCT00609791Phase 2Results posted
• Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By SurgeryCompletedNCT00559507Phase 2Results posted
• Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerCompletedNCT00513695Phase 2Results posted
• Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast CancerCompletedNCT00470301Phase 1/2Results posted
• ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous TreatmentCompletedNCT00425672Phase 1/2Results posted
• Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast CancerCompletedNCT00368875Phase 1/2Results posted
• Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast CancerCompletedNCT00343863Not applicableResults posted
• Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast CancerCompletedNCT00331552Phase 1/2Results posted
• Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast CancerActive, not recruitingNCT00295893Phase 2Results posted
• Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast CancerCompletedNCT00258349Phase 1/2Results posted
• A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)CompletedNCT00244881Phase 2Results posted
• Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast CancerTerminatedNCT00132002Phase 2Results posted
• Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast CancerCompletedNCT00119262Phase 2Results posted
• Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous TamoxifenCompletedNCT00118157Phase 2Results posted
• Pemetrexed as the First Treatment in Advanced or Metastatic Breast CancerCompletedNCT00106002Phase 2Results posted
• Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast CancerCompletedNCT00077376Phase 2Results posted
• S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast CancerActive, not recruitingNCT00070564Phase 3Results posted
• GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast CancerCompletedNCT00068588Phase 2Results posted
• Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast CancerTerminatedNCT00063934Phase 1/2Results posted
• Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerCompletedNCT00003199Phase 2Results posted
• Divergent Long-Term Clinical Courses in Two Men With Breast CancerCompletedNCT07865507
• EORTC Quality of Life Measurement in Males With Breast CancerCompletedNCT07455110
• Phase IIIb Study of Ribociclib + ET in Early Breast CancerActive, not recruitingNCT05827081Phase 3
• Testosterone & Tamoxifen TrialTerminatedNCT05156606Not applicable
• Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse RiskCompletedNCT03800355
• Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1TerminatedNCT03630809Phase 2
• HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast CancerCompletedNCT03387553Early Phase 1
• Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast CancerActive, not recruitingNCT03384914Phase 2
• PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer PatientWithdrawnNCT03295695Early Phase 1
• Understanding Male Breast Cancer: Salah Azaïz Cancer Institute ExperienceStatus unknownNCT03240510
• CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)CompletedNCT02580448Phase 1/2
• Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy SpecimensStatus unknownNCT02480933Not applicable
• Sense of Hope Alleviates Fatigue in Breast Cancer SurvivorsStatus unknownNCT02393105
• Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerCompletedNCT02206334Phase 1
• Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast CancerCompletedNCT02060253Phase 1
• Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02046421Phase 1
• Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By SurgeryCompletedNCT02013492Early Phase 1
• Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing ChemotherapyCompletedNCT01982591
• A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS MetastasesWithdrawnNCT01939483Not applicable
• Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS MetastasisCompletedNCT01783756Phase 1/2
• Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast CancerTerminatedNCT01729884Phase 2
• Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT01706432
• Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By SurgeryTerminatedNCT01705340Phase 1
• Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021).CompletedNCT01703520
• Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer PatientsCompletedNCT01638247Phase 3
• Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast CancerCompletedNCT01632332Phase 1
• Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast CancerCompletedNCT01624441Phase 1
• Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast CancerCompletedNCT01493310Phase 1
• Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer PatientsStatus unknownNCT01372579Phase 2
• Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast CancerCompletedNCT01355393Phase 1/2
• Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast CancerCompletedNCT01288261Phase 1
• Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT01281150Phase 1
• Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by SurgeryCompletedNCT01276496Phase 1
• Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast CancerCompletedNCT01245205Phase 1
• Endoscopic Breast Surgery in Treating Patients With Breast CancerTerminatedNCT01222377Not applicable
• Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast CancerWithdrawnNCT01219907Phase 1
• RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsCompletedNCT01158274Phase 1
• Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
• RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast CancerTerminatedNCT01149356Phase 1
• Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast CancerCompletedNCT01145430Phase 1
• Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsCompletedNCT01131234Phase 1
• Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast CancerCompletedNCT01104259Phase 1
• Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast CancerWithdrawnNCT01100489Phase 2
• Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast CancerCompletedNCT01084057Phase 1
• Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal SyndromeStatus unknownNCT00938756Not applicable
• Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerTerminatedNCT00937482Phase 1
• Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast CancerCompletedNCT00897702
• Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007CompletedNCT00773669
• Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1

← Breast Neoplasms, Male overview